Review
Rating scales for dyskinesias in Parkinson's disease
Affiliations
- PMID: 10493403
Item in Clipboard
Review
Rating scales for dyskinesias in Parkinson's disease
Mov Disord.
1999.
No abstract available
Similar articles
-
The phenomenology of L-dopa-induced dyskinesias in Parkinson's disease.Mov Disord. 1999;14 Suppl 1:13-8. Mov Disord. 1999. PMID: 10493399 Review. No abstract available.
-
A unified dyskinesias rating scale for L-dopa-induced dyskinesias?Mov Disord. 1999;14 Suppl 1:74. Mov Disord. 1999. PMID: 10493408 No abstract available.
-
[Social and economic cost of L-Dopa-induced dyskinesias in patients with Parkinson's disease].Rev Neurol (Paris). 2001 May;157(5):507-14. Rev Neurol (Paris). 2001. PMID: 11438770 French.
-
[Dyskinesia caused by L-DOPA].Rev Neurol (Paris). 2002 Dec;158 Spec no 1:S92-101. Rev Neurol (Paris). 2002. PMID: 12690668 Review. French.
-
L-dopa-induced peak-dose dyskinesias in patients with Parkinson's disease: a clinical pharmacologic approach.Mov Disord. 1999;14 Suppl 1:19-32. Mov Disord. 1999. PMID: 10493400 Review. No abstract available.
Cited by
-
Health-related quality of life and healthcare utilisation in patients with Parkinson's disease: impact of motor fluctuations and dyskinesias.Pharmacoeconomics. 2001;19(10):1013-38. doi: 10.2165/00019053-200119100-00004. Pharmacoeconomics. 2001. PMID: 11735671 Review.
-
Quantitative motor assessment of dyskinesias in Parkinson's disease.J Neural Transm (Vienna). 2015 Sep;122(9):1271-8. doi: 10.1007/s00702-015-1383-7. Epub 2015 Feb 25. J Neural Transm (Vienna). 2015. PMID: 25712401
-
The clinical spectrum of levodopa-induced motor complications.J Neurol. 2010 Nov;257(Suppl 2):S268-75. doi: 10.1007/s00415-010-5719-9. J Neurol. 2010. PMID: 21080188 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical